DE69412125T2 - Hornhautimplantat - Google Patents
HornhautimplantatInfo
- Publication number
- DE69412125T2 DE69412125T2 DE69412125T DE69412125T DE69412125T2 DE 69412125 T2 DE69412125 T2 DE 69412125T2 DE 69412125 T DE69412125 T DE 69412125T DE 69412125 T DE69412125 T DE 69412125T DE 69412125 T2 DE69412125 T2 DE 69412125T2
- Authority
- DE
- Germany
- Prior art keywords
- onlay
- corneal
- tissue
- cells
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007943 implant Substances 0.000 title description 36
- 240000008042 Zea mays Species 0.000 title 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 title 1
- 235000005822 corn Nutrition 0.000 title 1
- 230000003287 optical effect Effects 0.000 claims abstract description 37
- 239000012530 fluid Substances 0.000 claims abstract description 26
- 210000004087 cornea Anatomy 0.000 claims abstract description 23
- 239000000017 hydrogel Substances 0.000 claims abstract description 10
- 238000002513 implantation Methods 0.000 claims abstract description 10
- 230000004304 visual acuity Effects 0.000 claims abstract description 6
- 241000124008 Mammalia Species 0.000 claims abstract description 3
- 239000011148 porous material Substances 0.000 claims description 45
- 239000000463 material Substances 0.000 claims description 32
- 230000021164 cell adhesion Effects 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 6
- 238000004873 anchoring Methods 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 20
- 239000000560 biocompatible material Substances 0.000 abstract description 2
- 230000004907 flux Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 103
- 210000001519 tissue Anatomy 0.000 description 73
- 239000012528 membrane Substances 0.000 description 71
- 210000004379 membrane Anatomy 0.000 description 69
- 210000002966 serum Anatomy 0.000 description 60
- 210000002919 epithelial cell Anatomy 0.000 description 45
- 108010067306 Fibronectins Proteins 0.000 description 44
- 102000016359 Fibronectins Human genes 0.000 description 44
- 102100035140 Vitronectin Human genes 0.000 description 34
- 108010031318 Vitronectin Proteins 0.000 description 34
- 238000002474 experimental method Methods 0.000 description 22
- 239000004017 serum-free culture medium Substances 0.000 description 21
- 238000011282 treatment Methods 0.000 description 20
- 239000004793 Polystyrene Substances 0.000 description 19
- 229920002223 polystyrene Polymers 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 15
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 15
- 210000002744 extracellular matrix Anatomy 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 12
- 210000000981 epithelium Anatomy 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 12
- 108010085895 Laminin Proteins 0.000 description 11
- 102000007547 Laminin Human genes 0.000 description 11
- 239000010410 layer Substances 0.000 description 11
- 238000013508 migration Methods 0.000 description 11
- 102000012422 Collagen Type I Human genes 0.000 description 10
- 108010022452 Collagen Type I Proteins 0.000 description 10
- 230000005012 migration Effects 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- 241000282326 Felis catus Species 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000004936 stimulating effect Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000001228 trophic effect Effects 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 239000012894 fetal calf serum Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 101150116295 CAT2 gene Proteins 0.000 description 5
- 101100326920 Caenorhabditis elegans ctl-1 gene Proteins 0.000 description 5
- 206010029113 Neovascularisation Diseases 0.000 description 5
- 101100005280 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-3 gene Proteins 0.000 description 5
- 101100126846 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) katG gene Proteins 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000001617 migratory effect Effects 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 229940096422 collagen type i Drugs 0.000 description 4
- 210000003038 endothelium Anatomy 0.000 description 4
- 210000003560 epithelium corneal Anatomy 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000012679 serum free medium Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 3
- 101100392078 Caenorhabditis elegans cat-4 gene Proteins 0.000 description 3
- 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 101100112369 Fasciola hepatica Cat-1 gene Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 101100005271 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-1 gene Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 206010064996 Ulcerative keratitis Diseases 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000012888 bovine serum Substances 0.000 description 3
- 210000004045 bowman membrane Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000012292 cell migration Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 210000002555 descemet membrane Anatomy 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000834 fixative Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229960000907 methylthioninium chloride Drugs 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 210000001747 pupil Anatomy 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010055665 Corneal neovascularisation Diseases 0.000 description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- 101800003838 Epidermal growth factor Proteins 0.000 description 2
- 206010015548 Euthanasia Diseases 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 201000000159 corneal neovascularization Diseases 0.000 description 2
- 201000007717 corneal ulcer Diseases 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 229940116977 epidermal growth factor Drugs 0.000 description 2
- 210000005081 epithelial layer Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000032954 positive regulation of cell adhesion Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZTXSPLGEGCABFL-UHFFFAOYSA-N 1.1.1-propellane Chemical compound C1C23CC31C2 ZTXSPLGEGCABFL-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 208000030275 Chondronectin Diseases 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000007227 biological adhesion Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940096423 bovine collagen type i Drugs 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 230000004453 corneal transparency Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920006240 drawn fiber Polymers 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000013628 high molecular weight specie Substances 0.000 description 1
- 108700020610 human chondronectin Proteins 0.000 description 1
- 102000043667 human chondronectin Human genes 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 108010004563 mussel adhesive protein Proteins 0.000 description 1
- 239000003988 mussel adhesive protein Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- -1 poly(1-octene-1,8-diyl) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920003245 polyoctenamer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000006444 vascular growth Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/145—Corneal inlays, onlays, or lenses for refractive correction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Catalysts (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM254993 | 1993-11-19 | ||
| PCT/EP1994/003680 WO1995013764A1 (en) | 1993-11-19 | 1994-11-09 | Corneal onlays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69412125D1 DE69412125D1 (de) | 1998-09-03 |
| DE69412125T2 true DE69412125T2 (de) | 1999-05-06 |
Family
ID=3777369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69412125T Expired - Lifetime DE69412125T2 (de) | 1993-11-19 | 1994-11-09 | Hornhautimplantat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5713957A (enExample) |
| EP (1) | EP0729323B1 (enExample) |
| JP (1) | JPH09504706A (enExample) |
| KR (1) | KR100355168B1 (enExample) |
| CN (1) | CN1135168A (enExample) |
| AT (1) | ATE168879T1 (enExample) |
| CZ (1) | CZ286070B6 (enExample) |
| DE (1) | DE69412125T2 (enExample) |
| DK (1) | DK0729323T3 (enExample) |
| ES (1) | ES2122345T3 (enExample) |
| FI (1) | FI962094A7 (enExample) |
| HU (1) | HU222185B1 (enExample) |
| IL (1) | IL111578A (enExample) |
| NO (1) | NO306805B1 (enExample) |
| NZ (1) | NZ275119A (enExample) |
| PL (1) | PL177096B1 (enExample) |
| SG (1) | SG45284A1 (enExample) |
| TW (1) | TW257671B (enExample) |
| WO (1) | WO1995013764A1 (enExample) |
| ZA (1) | ZA949170B (enExample) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090069817A1 (en) * | 1995-10-20 | 2009-03-12 | Acufocus, Inc. | Intrastromal corneal modification |
| US20050143717A1 (en) * | 2001-04-27 | 2005-06-30 | Peyman Gholam A. | Method of treatment of refractive errors using subepithelial or intrastromal corneal inlay with bonding coating |
| US6361560B1 (en) * | 1998-12-23 | 2002-03-26 | Anamed, Inc. | Corneal implant and method of manufacture |
| US6554424B1 (en) * | 1999-03-01 | 2003-04-29 | Boston Innovative Optices, Inc. | System and method for increasing the depth of focus of the human eye |
| GB0016008D0 (en) * | 2000-06-29 | 2000-08-23 | Nokia Networks Oy | Capacity changes in transceiver apparatus |
| US6544286B1 (en) * | 2000-07-18 | 2003-04-08 | Tissue Engineering Refraction, Inc. | Pre-fabricated corneal tissue lens method of corneal overlay to correct vision |
| AR030341A1 (es) * | 2000-08-14 | 2003-08-20 | Novartis Ag | Articulos biomedicos moldeados |
| JP2004526467A (ja) | 2000-09-12 | 2004-09-02 | アナメッド インク． | 移植片のパッケージおよび取扱のためのシステムおよび使用方法 |
| US8668735B2 (en) | 2000-09-12 | 2014-03-11 | Revision Optics, Inc. | Corneal implant storage and delivery devices |
| WO2003096876A2 (en) * | 2001-04-01 | 2003-11-27 | Sommer Phillipe L | Continuously operational diagnostic device |
| US20050182489A1 (en) * | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Intraocular lens adapted for adjustment via laser after implantation |
| US20050222679A1 (en) * | 2001-04-27 | 2005-10-06 | Peyman Gholam A | Bifocal implant and method for altering the refractive properties of the eye |
| US20050182488A1 (en) * | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Implant and method for altering the refractive properties of the eye |
| GB0121168D0 (en) * | 2001-08-31 | 2001-10-24 | Duckworth & Kent Ltd | Ophthalmic devices and procedures |
| KR20030032420A (ko) * | 2001-10-18 | 2003-04-26 | 한국과학기술연구원 | 손상된 안구 조직의 재생을 위한 생분해성 고분자로제조된 다공성 지지체 |
| EP1474084A4 (en) * | 2002-01-17 | 2007-04-18 | Edward Perez | METHODS FOR REALIZING EPITHELIAL RECOVERY ON THE CORNEA AND FOR PLACING OCULAR DEVICES AND LENSES UNDER EPITHELIAL RECOVERY OR EPITHELIAL MEMBRANE, EPITHELIAL DETACHING DEVICES, EPITHELIUM STRUCTURES, DEVICES AND OCULAR LENSES |
| US7364674B1 (en) * | 2002-07-23 | 2008-04-29 | Advanced Optical Technologies, Inc. | Corneal implants produced by irradiation of polymer films |
| MXPA05002669A (es) * | 2002-09-13 | 2005-08-19 | Ocular Sciences Inc | Dispositivos y metodos para mejorar la vision. |
| DE60223582T2 (de) * | 2002-12-24 | 2008-09-04 | Medical Technology Transfer Holding B.V. | Kosmetisches Augenimplantat |
| US7628810B2 (en) * | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
| US20050046794A1 (en) * | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
| DE102004002990A1 (de) * | 2004-01-21 | 2005-08-18 | Robert Dr. Simmoteit | Material und Verfahren zum Stoffaustausch und Stofftransfer |
| WO2005072223A2 (en) | 2004-01-23 | 2005-08-11 | California Institute Of Technology | Engineered proteins, and methods of making and using |
| US10835371B2 (en) | 2004-04-30 | 2020-11-17 | Rvo 2.0, Inc. | Small diameter corneal inlay methods |
| CA2566961A1 (en) | 2004-05-20 | 2005-12-08 | Coopervision, Inc. | Corneal onlays and wavefront aberration correction to enhance vision |
| WO2006019893A2 (en) * | 2004-07-15 | 2006-02-23 | Coopervision, Inc. | Intrastromal devices and method for improving vision |
| US20060134170A1 (en) * | 2004-08-13 | 2006-06-22 | May Griffith | Vision enhancing ophthalmic devices and related methods and compositions |
| CA2614519A1 (en) * | 2004-10-22 | 2006-05-04 | Omer Yilmaz | System and method for aligning an optic with an axis of an eye |
| US20060113054A1 (en) * | 2004-12-01 | 2006-06-01 | Silvestrini Thomas A | Method of making an ocular implant |
| US7491350B2 (en) * | 2004-12-01 | 2009-02-17 | Acufocus, Inc. | Method of making an ocular implant |
| US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
| US20060235428A1 (en) * | 2005-04-14 | 2006-10-19 | Silvestrini Thomas A | Ocular inlay with locator |
| AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| CA2613889A1 (en) * | 2005-06-08 | 2006-12-14 | Centocor, Inc. | A cellular therapy for ocular degeneration |
| US20070182920A1 (en) * | 2006-02-08 | 2007-08-09 | Coopervision, Inc. | Corneal Onlays and Related Methods |
| US10555805B2 (en) | 2006-02-24 | 2020-02-11 | Rvo 2.0, Inc. | Anterior corneal shapes and methods of providing the shapes |
| US7883520B2 (en) * | 2006-04-10 | 2011-02-08 | Forsight Labs, Llc | Corneal epithelial pocket formation systems, components and methods |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| WO2008109077A2 (en) * | 2007-03-02 | 2008-09-12 | Doheny Eye Institute | Nanoscale surface activation of silicone via laser processing |
| WO2008143733A2 (en) * | 2007-03-02 | 2008-11-27 | Dohney Eye Institute | Biocompatible implants and methods of making and attaching the same |
| US8162953B2 (en) | 2007-03-28 | 2012-04-24 | Revision Optics, Inc. | Insertion system for corneal implants |
| US9549848B2 (en) | 2007-03-28 | 2017-01-24 | Revision Optics, Inc. | Corneal implant inserters and methods of use |
| US9271828B2 (en) | 2007-03-28 | 2016-03-01 | Revision Optics, Inc. | Corneal implant retaining devices and methods of use |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| MX2010001335A (es) | 2007-07-31 | 2010-06-02 | Lifescan Inc | Diferenciacion de celulas madre embrionarias humanas. |
| JP5710264B2 (ja) | 2007-11-27 | 2015-04-30 | ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． | ヒト胚性幹細胞の分化 |
| CN105886459A (zh) | 2008-02-21 | 2016-08-24 | 詹森生物科技公司 | 用于细胞粘附、培养和分离的方法、表面改性培养板和组合物 |
| US9539143B2 (en) | 2008-04-04 | 2017-01-10 | Revision Optics, Inc. | Methods of correcting vision |
| US9125735B2 (en) * | 2008-04-04 | 2015-09-08 | Forsight Labs, Llc | Method of correcting vision using corneal onlays |
| CA2720250C (en) | 2008-04-04 | 2018-01-23 | Forsight Labs, Llc | Therapeutic device for pain management and vision |
| AU2009231636B2 (en) | 2008-04-04 | 2014-07-24 | Revision Optics, Inc. | Corneal inlay design and methods of correcting vision |
| EP2296580A2 (en) * | 2008-04-04 | 2011-03-23 | Forsight Labs, Llc | Corneal onlay devices and methods |
| US20090306773A1 (en) * | 2008-06-04 | 2009-12-10 | Acufocus, Inc. | Opaque corneal insert for refractive correction |
| MX2011000125A (es) | 2008-06-30 | 2011-02-25 | Centocor Ortho Biotech Inc | Diferenciacion de celulas madre pluripotentes. |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| US20100087920A1 (en) * | 2008-10-07 | 2010-04-08 | Forsight Labs, Llc | Corneal Onlay Lenses and Related Methods for Improving Vision of Presbyopic Patients |
| ES2727950T3 (es) * | 2008-10-31 | 2019-10-21 | Janssen Biotech Inc | Diferenciación de células madre embrionarias humanas en linaje endocrino pancreático |
| PL2346988T3 (pl) | 2008-10-31 | 2017-10-31 | Janssen Biotech Inc | Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki |
| MX356756B (es) | 2008-11-20 | 2018-06-11 | Centocor Ortho Biotech Inc | Células madre pluripotentes en microportadores. |
| ES2584053T3 (es) * | 2008-11-20 | 2016-09-23 | Janssen Biotech, Inc. | Métodos y composiciones para la unión de células y cultivo en sustratos planos |
| DE202008015910U1 (de) | 2008-12-02 | 2009-03-05 | Lee, Kuo-Jen | Abnehmbarer Gepäckträger und Riegelvorrichtung eines Schlosses für ein Zweirad |
| KR101786735B1 (ko) | 2009-07-20 | 2017-10-18 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| WO2011011302A2 (en) * | 2009-07-20 | 2011-01-27 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
| SG177481A1 (en) | 2009-07-20 | 2012-02-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
| US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
| BR112012008083A2 (pt) * | 2009-08-13 | 2016-04-19 | Acufocus Inc | lentes e implantes intraoculares ocultos |
| AU2010282307A1 (en) | 2009-08-13 | 2012-04-05 | Acufocus, Inc. | Corneal inlay with nutrient transport structures |
| US9498385B2 (en) | 2009-10-23 | 2016-11-22 | Nexisvision, Inc. | Conformable therapeutic shield for vision and pain |
| US8591025B1 (en) | 2012-09-11 | 2013-11-26 | Nexisvision, Inc. | Eye covering and refractive correction methods for LASIK and other applications |
| EP3260092A1 (en) | 2009-10-23 | 2017-12-27 | Nexisvision, Inc. | Corneal denervation for treatment of ocular pain |
| USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
| CA2784415C (en) | 2009-12-23 | 2019-06-18 | Jean Xu | Differentiation of human embryonic stem cells |
| KR101764404B1 (ko) | 2009-12-23 | 2017-08-03 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| PH12012501686A1 (en) * | 2010-03-01 | 2020-10-19 | Janssen Biotech Inc | Methods for purifying cells derived from pluripotent stem cells |
| JP6050225B2 (ja) | 2010-05-12 | 2016-12-21 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の分化 |
| MX355077B (es) | 2010-08-31 | 2018-04-03 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas. |
| EP3372672A1 (en) | 2010-08-31 | 2018-09-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| ES2585028T3 (es) | 2010-08-31 | 2016-10-03 | Janssen Biotech, Inc. | Diferenciación de células madre pluripotentes |
| EP2632405A4 (en) | 2010-10-25 | 2016-02-24 | Nexisvision Inc | METHODS AND APPARATUSES FOR IDENTIFYING EYE RECOVERY ELEMENTS FOR SIGHT |
| US12044905B2 (en) | 2011-04-28 | 2024-07-23 | Journey1 Inc | Contact lenses for refractive correction |
| CN103648448B (zh) | 2011-04-28 | 2016-11-09 | 内希斯视觉股份有限公司 | 具有改善泪流、舒适度和/或适用性的眼覆盖物和屈光校正方法和装置 |
| EP2768430A4 (en) | 2011-10-21 | 2015-05-20 | Revision Optics Inc | CORNEAL IMPLANT STORAGE AND INSTALLATION DEVICES |
| EP2785296B1 (en) | 2011-12-02 | 2018-06-20 | AcuFocus, Inc. | Ocular mask having selective spectral transmission |
| JP6441080B2 (ja) | 2011-12-22 | 2018-12-19 | ヤンセン バイオテツク，インコーポレーテツド | 単一ホルモンのインスリン陽性細胞へのヒト胚性幹細胞の分化 |
| HK1206058A1 (en) | 2012-03-07 | 2015-12-31 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| CN104335104B (zh) | 2012-04-20 | 2017-06-09 | 内希斯视觉股份有限公司 | 用于屈光矫正的接触透镜 |
| US9465233B2 (en) | 2012-04-20 | 2016-10-11 | Nexisvision, Inc. | Bimodular contact lenses |
| CN108103005A (zh) | 2012-06-08 | 2018-06-01 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| WO2014039495A1 (en) | 2012-09-05 | 2014-03-13 | University Of Miami | Novel keratoprosthesis, and system and method of corneal repair using same |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| RU2658488C2 (ru) | 2012-12-31 | 2018-06-21 | Янссен Байотек, Инк. | Способ получения клеток, экспрессирующих маркеры, характерные для панкреатических эндокринных клеток |
| AU2013368224B2 (en) | 2012-12-31 | 2018-09-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators |
| MX2015008619A (es) | 2012-12-31 | 2016-01-12 | Janssen Biotech Inc | Suspension y agrupamiento de celulas humanas pluripotentes para la diferenciacion a celulas endocrinas pancreaticas. |
| US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
| US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
| JP6310072B2 (ja) | 2013-06-26 | 2018-04-11 | ネクシスビジョン， インコーポレイテッド | 屈折矯正のためのコンタクトレンズ |
| US9341864B2 (en) | 2013-11-15 | 2016-05-17 | Nexisvision, Inc. | Contact lenses having a reinforcing scaffold |
| WO2015116559A1 (en) | 2014-01-29 | 2015-08-06 | Nexisvision, Inc. | Multifocal bimodulus contact lenses |
| EP3954759A1 (en) | 2014-05-16 | 2022-02-16 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| CN106999278A (zh) | 2014-11-19 | 2017-08-01 | 阿库福库斯公司 | 用于治疗老视的可断裂掩盖物 |
| WO2016144404A1 (en) | 2015-03-12 | 2016-09-15 | Revision Optics, Inc. | Methods of correcting vision |
| WO2017062316A1 (en) | 2015-10-05 | 2017-04-13 | Acufocus, Inc. | Methods of molding intraocular lenses |
| EP3384342B1 (en) | 2015-11-24 | 2021-08-25 | AcuFocus, Inc. | Toric small aperture intraocular lens with extended depth of focus |
| SE539167C2 (en) * | 2015-12-22 | 2017-05-02 | Rafat Mehrdad | A composite collagen hydrogel material, an implantable ophthalmic device comprising such material and methods of producing the composite collagen hydrogel material and the implantable ophthalmic device |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| US11364110B2 (en) | 2018-05-09 | 2022-06-21 | Acufocus, Inc. | Intraocular implant with removable optic |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4624669A (en) * | 1984-09-26 | 1986-11-25 | Surgidev Corporation | Corneal inlay with holes |
| US4621912A (en) * | 1985-02-14 | 1986-11-11 | Meyer Donald R | Foraminated optical contact lens |
| US4799931A (en) * | 1986-05-14 | 1989-01-24 | Lindstrom Richard L | Intracorneal lens |
| US5244799A (en) * | 1987-05-20 | 1993-09-14 | Anderson David M | Preparation of a polymeric hydrogel containing micropores and macropores for use as a cell culture substrate |
| US4911717A (en) * | 1987-06-18 | 1990-03-27 | Gaskill Iii Harold V | Intravasular artificial organ |
| US4810082A (en) * | 1987-07-01 | 1989-03-07 | Abel Robert Jr | Corneal onlay lens |
| US4865601A (en) * | 1987-07-07 | 1989-09-12 | Caldwell Delmar R | Intraocular prostheses |
| US4795462A (en) * | 1987-08-24 | 1989-01-03 | Grendahl Dennis T | Cylindrically segmented zone of focus artificial lens |
| US5171318A (en) * | 1987-11-09 | 1992-12-15 | Chiron Ophthalmics, Inc. | Treated corneal prosthetic device |
| US4851003A (en) * | 1988-01-05 | 1989-07-25 | Lindstrom Richard L | Corneal implant lens with fixation holes |
| US5192316A (en) * | 1988-02-16 | 1993-03-09 | Allergan, Inc. | Ocular device |
| US5108428A (en) * | 1988-03-02 | 1992-04-28 | Minnesota Mining And Manufacturing Company | Corneal implants and manufacture and use thereof |
| FR2630638B1 (fr) * | 1988-05-02 | 1997-08-08 | Inst Nat Sante Rech Med | Implant oculaire et son procede de preparation |
| JP2763776B2 (ja) * | 1988-05-27 | 1998-06-11 | 日本原子力研究所 | 細孔化コンタクトレンズの製造法 |
| US4994080A (en) * | 1988-07-15 | 1991-02-19 | Shepard Dennis D | Optical lens having at least one stenopaeic opening located in the central area thereof |
| JPH05501971A (ja) * | 1989-09-15 | 1993-04-15 | カイロン・オフサルミクス・インコーポレイテッド | 合成レンズの上皮化達成法 |
| GB8925302D0 (en) * | 1989-11-09 | 1989-12-28 | Nat Res Dev | Gas-permeable contact lens |
| AU3469893A (en) * | 1992-01-15 | 1993-08-03 | Allergan, Inc. | Hydrogel compositions and structures made from same |
-
1994
- 1994-03-08 TW TW083101993A patent/TW257671B/zh active
- 1994-11-09 AT AT94931590T patent/ATE168879T1/de not_active IP Right Cessation
- 1994-11-09 PL PL94314525A patent/PL177096B1/pl unknown
- 1994-11-09 DE DE69412125T patent/DE69412125T2/de not_active Expired - Lifetime
- 1994-11-09 HU HU9601345A patent/HU222185B1/hu not_active IP Right Cessation
- 1994-11-09 US US08/646,287 patent/US5713957A/en not_active Expired - Lifetime
- 1994-11-09 KR KR1019960702637A patent/KR100355168B1/ko not_active Expired - Fee Related
- 1994-11-09 DK DK94931590T patent/DK0729323T3/da active
- 1994-11-09 CN CN94194202A patent/CN1135168A/zh active Pending
- 1994-11-09 CZ CZ19961429A patent/CZ286070B6/cs not_active IP Right Cessation
- 1994-11-09 SG SG1996002738A patent/SG45284A1/en unknown
- 1994-11-09 ES ES94931590T patent/ES2122345T3/es not_active Expired - Lifetime
- 1994-11-09 NZ NZ275119A patent/NZ275119A/en unknown
- 1994-11-09 EP EP94931590A patent/EP0729323B1/en not_active Expired - Lifetime
- 1994-11-09 WO PCT/EP1994/003680 patent/WO1995013764A1/en not_active Ceased
- 1994-11-09 JP JP7506621A patent/JPH09504706A/ja active Pending
- 1994-11-10 IL IL11157894A patent/IL111578A/xx active IP Right Grant
- 1994-11-18 ZA ZA949170A patent/ZA949170B/xx unknown
-
1996
- 1996-05-14 NO NO961980A patent/NO306805B1/no not_active IP Right Cessation
- 1996-05-17 FI FI962094A patent/FI962094A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0729323A1 (en) | 1996-09-04 |
| IL111578A (en) | 1999-04-11 |
| SG45284A1 (en) | 1998-01-16 |
| CZ286070B6 (cs) | 2000-01-12 |
| ES2122345T3 (es) | 1998-12-16 |
| EP0729323B1 (en) | 1998-07-29 |
| PL314525A1 (en) | 1996-09-16 |
| ATE168879T1 (de) | 1998-08-15 |
| CN1135168A (zh) | 1996-11-06 |
| IL111578A0 (en) | 1995-01-24 |
| KR960705513A (ko) | 1996-11-08 |
| HU222185B1 (hu) | 2003-06-28 |
| NO961980D0 (no) | 1996-05-14 |
| DE69412125D1 (de) | 1998-09-03 |
| WO1995013764A1 (en) | 1995-05-26 |
| ZA949170B (en) | 1995-07-07 |
| NO306805B1 (no) | 1999-12-27 |
| NO961980L (no) | 1996-05-14 |
| NZ275119A (en) | 1997-10-24 |
| HUT74277A (en) | 1996-11-28 |
| FI962094A7 (fi) | 1996-05-20 |
| PL177096B1 (pl) | 1999-09-30 |
| US5713957A (en) | 1998-02-03 |
| CZ142996A3 (en) | 1996-10-16 |
| FI962094A0 (fi) | 1996-05-17 |
| HU9601345D0 (en) | 1996-07-29 |
| KR100355168B1 (ko) | 2005-04-06 |
| TW257671B (enExample) | 1995-09-21 |
| DK0729323T3 (da) | 1999-05-03 |
| JPH09504706A (ja) | 1997-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69412125T2 (de) | Hornhautimplantat | |
| DE69917651T2 (de) | Hornhautlinse | |
| DE69534869T2 (de) | Matrix für Gewebekultur, Verfahren zum Züchten von Gewebe, Verfahren zur Befestigung von gezüchtetem Gewebe und befestigte Kunsthaut | |
| DE69634828T2 (de) | Auffindbare künstliche bioimplantate | |
| DE3751843T2 (de) | Herstellung von körperorganen durch kontroliertes zellwachstum auf künstlicher matrix | |
| DE60312525T2 (de) | Biosynthetische matrix und deren verwendung | |
| DE69128530T2 (de) | Zusammengesetztes äquivalent der lebenden haut | |
| DE69329334T2 (de) | Systeme für die implantierung von zellen | |
| DE69016086T2 (de) | Verfahren zum Züchten von Zellgewebe. | |
| KR101317094B1 (ko) | 멤브레인 | |
| CA2174967C (en) | Corneal onlays | |
| EP1980274B1 (en) | Corneal endothelial preparation which enables cells to grow in vivo | |
| JP2008538523A (ja) | 人工角膜 | |
| DE3850957T2 (de) | Neutralisierte perfluoro-3,6-dioxa-4-methyl-7-octen sulphonyl fluorid kopolymer fläche zur befestigung und zucht tierischer zellen. | |
| DE3904741A1 (de) | Okularvorrichtung | |
| Field et al. | Selective innervation of embryonic hippocampal transplants by adult host dentate granule cell axons | |
| DE60027724T2 (de) | Verbesserte keratinozytenkultur und deren verwendungen | |
| DE202020005758U1 (de) | Biotechnologische Hornhauttransplantate | |
| Grant et al. | Embryonic and regenerating Xenopus retinal fibers are intrinsically different | |
| KR20030032420A (ko) | 손상된 안구 조직의 재생을 위한 생분해성 고분자로제조된 다공성 지지체 | |
| Dupont et al. | Biocompatibility of human collagen type IV intracorneal implants | |
| AU682907B2 (en) | Corneal onlays | |
| DE10062623B4 (de) | Dreidimensionales Hautmodell | |
| EP4433110B1 (de) | Stützmembran sowie verfahren zur herstellung einer stützmembran | |
| DE10030307A1 (de) | Mit Blut und Gewebe verträgliche Membranen aus P(AN/NVP)-Mischpolymeren und deren Anwendung im medizinischen Bereich |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de | ||
| 8370 | Indication related to discontinuation of the patent is to be deleted | ||
| 8364 | No opposition during term of opposition |